Arcutis Biotherapeutics, Inc.
ARQT
Clasificación en acciones
#4366
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Precio por acción
$28.54
Última sincronización: 2026-10-16
Capitalización bursátil
$3.59B
Cambio (1 día)
-1.94%
Cambio (1 año)
36.66%
País
US
Comercio Arcutis Biotherapeutics, Inc. (ARQT)
Categoría
Healthcare
EPS de Arcutis Biotherapeutics, Inc. (ARQT)
EPS a fecha de June 2026 TTM: $0.22
Según los últimos informes financieros y el precio de las acciones de Arcutis Biotherapeutics, Inc., el EPS actual de la empresa (TTM) es $0.22. Al final del año 2023, la empresa tenía un EPS de $-3.78 una disminución en comparación con al EPS de 2022, que fue de $-5.66.
Historial de EPS de Arcutis Biotherapeutics, Inc. desde 2017 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.22 | -118.97% |
| 2024 | $-1.16 | -69.31% |
| 2023 | $-3.78 | -33.22% |
| 2022 | $-5.66 | 35.73% |
| 2021 | $-4.17 | 9.74% |
| 2020 | $-3.80 | 245.45% |
| 2019 | $-1.10 | 107.55% |
| 2018 | $-0.53 | -88.75% |
| 2017 | $-4.71 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $17.32 | 7,772.73% |
US
|
|
| $-7.98 | -3,727.27% |
US
|
|
| $-5.29 | -2,504.55% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 12,509.09% |
NL
|
